2007
Ferrara, Joseph V., "Personalized Medicine: Challenging Pharmaceutical and Diagnostic Company Business Models", McGill Journal of Medicine, Vol 10, No 1, 2007
2006
Robbertz, A., Lauf, R., Rupp, R., Alexander, D., "A qualitative assessment of dental care access and utilization among the older adult population in the United States", AGD General Dentistry, September/October 2006, Vol 54, No 5
A Guide to US Reimbursement for Drugs, Medical Devices, and Diagnostics, D&MD Publications, April 2006, Report #9202
Updated: A comprehensive review of how medical technologies secure payment from private and public payers. The guide examines coverage, coding and payment issues from private payer (HMO, PPO) and public payer (Medicare, Medicaid) perspectives.
Ferrara, Joseph V., "Personalized Medicine: Challenges in Assessing and Capturing Value in the Commercial Environment", Expert Review of Molecular Diagnostics, Future Drugs, Ltd, March 2006, Vol 6, No 2
2005
Zick,
C.D., Mathews, C.J., Roberts, J.S., Cook-Deegan, R.,
Pokorski, R.J., Green, R.C., "Genetic
Testing For Alzheimer's Disease And Its Impact On
Insurance Purchasing Behavior",
Health Affairs, March/April edition, 2005
2004
Stewart, Maria B., "Reimbursement Q&A",
UroTrends Newsletter, Spring 2004, Vol 9, No 1.
"Is there any easy way to ensure your molecular
Dx is reimbursable?", SNPtech
Pharmacogenomics Reporter, Perspectives, March
25, 2004, interview with Maria B. Stewart.
Anderson, D.Q. "Early-Stage
Biotechnology Partnering and Deal Making - Drivers,
Deals, and Direction for 2004", Drug &
Market Development Newsletter, March 2004
2003
MX:
Issues Update, "Coalition
Urges Adoption of MIRA Reforms", October
2003, quoted by Jo Ellen Slurzberg
"A
Guide To Achieving Reimbursement For Medical Devices,
Diagnostics, and Pharmaceuticals in the United States", This
Guide explores the basics of reimbursement and provides
companies with the tools to navigate through this
complex process. In addition, the Guide highlights
the latest policy and legislative initiatives that
have significantly impacted the industry.
Anderson
,
D.Q. "Mergers and Acquisitions in the Healthcare Sector
- Part 2: Medical Devices and Diagnostics",
In Press, Drug & Market Development Newsletter,
September 2003
Anderson
,
D.Q. "Mergers
and Acquisitions in the Healthcare Sector - Part 1:
Pharmaceuticals and Biotechnology", In Press,
Drug & Market Development Newsletter, August 2003
Anderson
, D.Q. "Adjustment
issues", The Deal, 1 (26),
May 19th, 2003
Anderson, D.Q. "Bio
burnout", The Deal, 1 (18),
March 24th, 2003
Anderson
,
D.Q. "Financial Crisis in the Biotechnology Industry",
Drug & Market Development Newsletter, February 2003
Ferrara
,
J.V. "Is
the current reimbursement structure limiting R&D
in IVDs?", IVD Technology, 9 (1), January/February
2003
Next
|